Table 2.
Cancers prospectively detected in the BRCA2 c.68-7T> A carriers
| Patient | Diagnosis | Diagnostic method | Age years | Years follow-up to cancer | Histopathology | Cancer before follow-up |
|---|---|---|---|---|---|---|
| 1 | Breast cancer right side | Mammography | 58 | 14.1 | Ductal cancer; 15 mm; high grade; pTNM:100; estrogen receptor (ER) negative; progesterone receptor (PR) negative | |
| Breast cancer left side | Mammography | 58 | 14.1 | Ductal carcinoma in situ; 40 mm; high grade | ||
| 2 | Breast cancer left side | Mammography | 68 | 9.9 | Ductal cancer; high grade; 35 mm; pTNM:200; ER positive; PR positive | Breast cancer 47 years |
| 3 | Breast cancer right side | MRI | 40 | First examination | Ductal cancer; high grade; 30 mm; pTNM:200; ER negative; PR negative | |
| 4 | Ovarian cancer | Prophylactic surgery | 0 | Borderline tumor |